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Background: Although stem cell mobilization has been shown to be depressed in advanced chronic heart failure the underlying mechanisms 
remain undefined. We sought to identify parameters associated with poor stem cell mobilization in this patient cohort.
Methods: In a prospective study we enrolled 44 patients with advanced chronic heart failure failure (NYHA III and IV, LVEF<40%) who underwent 
5-day bone marrow stimulation with daily subcutaneous injections of G-CSF (5 μg/kg bid). On the fifth day we measured peripheral blood CD34+ cell 
count. Poor stem cell mobilization was defined as peripheral CD34+ count< 40 million.
Results: Poor CD34+ mobilization was present in 25 patients (56%). Poor and normal mobilizers did not differ significantly with regards to age 
(54±9 years in poor mobilizers vs. 52±9 years in normal mobilizers; P= 0.48), LVEF (23±8 % vs. 25±7 %; P=0.38), LVEDD (6.99±1.02 cm vs. 
7.11±0.9 cm; P=0.77), creatinine (114±44 μmol/L vs. 94±22 μmol/L; P=0.08), bilirubine (24.6±12.7 μmol/L vs. 19.6±9.7 μmol/L, P=0.10) and 
exercise capacity (6-minute walk test distance: 353±122 m vs. 380±97 m; P=0.52). However, when compared to normal mobilizers, poor mobilizers 
had significantly higher NT-proBNP levels (6486±8102 pg/mL vs. 1868±1864 pg/mL in normal mobilizers; P=0.03) and higher red cell distribution 
width (RDW: 16.14±3.05 % vs. 13.82±1.33% in normal mobilizers; P=0.004). Increased RDW (>14%) was the only independent predictor of poor 
stem cell mobilization on multivariate analysis (P=0.01).
Conclusions: Poor stem cell mobilization in patients with advanced chronic heart failure is associated with increased RDW. This suggests that the 
mechanisms leading to ineffective erythropoiesis may also impair bone marrow stem-cell reserve in these patients. Since lower numbers of mobilized 
cells lead to less pronounced clinical effects in stem cell transplantation, increased RDW may serve as a simple, inexpensive tool to identify poor 
responders to stem cell therapy.
